Hall_Br J Cancer_1991
The present study was designed to evaluate the risk of second primary cancer in a cohort of thyroid cancer patients treated with Iodine 131, and to contrast the risk with that of nonexposed thyroid cancer patients. *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
- Start Year
- End Year
- Study design
- Clinical trial cohort
- Follow Up
- Observation period was 10 years or more.
Hall, P., Holm, LE., Lundell, G. et al. Cancer risks in thyroid cancer patients. Br J Cancer 64, 159–163 (1991). https://doi.org/10.1038/bjc.1991.261
- Sources of Recruitment
Number of participants
- Number of participants
- Number of participants with biosamples
- Supplementary Information
- Thyroid cancer patients under 76 years old.
Availability of data and biosamples
No coverage data about the variables classifications are available.